Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

Conditions

CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization — DEVICE
Implantation of CardioMEMS Device in patients following admission for Cardiogenic shock, with regular ambulatory pulmonary artery pressure monitoring and medication optimization for the treatment of heart failure.

Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock

Experimental: CardioMEMS Implant Group
Following enrollment, patients randomized 1:1 to post-discharge implantation of the CardioMEMS device will receive that device ≤14 days following discharge from the index hospitalization for Cardiogenic Shock, in addition to local standard of care medical therapy.
No Intervention: Non-CardioMEMS Implant Group
Following enrollment, patients randomized 1:1 to post-discharge standard of care will be treated according to local standard of care medical therapy following their index hospitalization for Cardiogenic Shock.

Hierarchical primary endpoint [ Time Frame: 6 months ]

Facility	City	State	ZIP	Site coordinators
Inova Fairfax Medical Campus	Falls Church	Virginia	22042	Bhruga Shah, MS, BSN [email protected] 703-776-2828 Kedir Seid [email protected] 17037762524 Shashank Sinha, MD MSc (PRINCIPAL_INVESTIGATOR)

By condition

By specialty

By research site